CDKN2C
CDKN2C (cyclin dependent kinase inhibitor 2C, also known as INK4C or p18) is a member of the INK4 family of cyclin-dependent kinase inhibitors. It binds CDK4 and CDK6 and acts as a cell growth regulator that controls G1 progression of the cell cycle. Browse Assay Genie's current range of CDKN2C research reagents below, or read on for the biology behind the target.
CDKN2C is a cyclin-dependent kinase inhibitor that restrains cell growth and proliferation. The protein interacts strongly with CDK6 and more weakly with CDK4. By binding these kinases it prevents their activation, and in this way it regulates progression through the G1 phase of the cell cycle. Its growth-inhibitory activity shows a correlated dependence on endogenous retinoblastoma protein (RB). Ectopic expression of the CDKN2C gene suppressed the growth of human cells in a manner that appears to correlate with the presence of wild-type RB1 function.
The CDKN2C protein is a member of the INK4 family and belongs to the CDKN2 cyclin-dependent kinase inhibitor family. HGNC classes it within the ankyrin repeat domain containing group and the cyclin dependent kinase inhibitor 2 family. The gene is located on human chromosome 1, and a mouse ortholog, Cdkn2c, is recognised. Two alternatively spliced transcript variants have been reported, and both encode an identical protein.
The official name was previously written as cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4), and the aliases INK4C and p18 remain in common use in the literature. Studies in knockout mice point to roles for the gene in regulating spermatogenesis and in suppressing tumorigenesis, which makes the CDKN2C protein a useful subject for work on cell cycle control and growth regulation.
CDKN2C binds CDK4 and CDK6 and controls G1 progression, making it a focus for studies of how the cell cycle is regulated.
Knockout mouse studies suggest CDKN2C suppresses tumorigenesis, and its growth inhibition correlates with wild-type RB1 function.
Mouse knockout studies indicate that the CDKN2C gene has a role in regulating spermatogenesis.
As an INK4 member, CDKN2C is studied alongside other CDK inhibitors to compare how each restrains CDK4 and CDK6 activity.
CDKN2C interacts with CDK4 and CDK6, interacting strongly with CDK6 and weakly with CDK4, and prevents activation of these kinases. This controls G1 progression and inhibits cell growth and proliferation, with a correlated dependence on endogenous RB.
CDKN2C is also called INK4C and p18. The older gene name was cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4), and UniProt lists the protein as cyclin-dependent kinase 4 inhibitor C. Two splice variants have been reported, both encoding an identical protein.
A mouse ortholog, Cdkn2c, exists. Knockout mouse studies suggested roles in regulating spermatogenesis and in suppressing tumorigenesis. Check the datasheet of any product for its validated reactivity before choosing reagents for a given species.
Other cyclin-dependent kinase inhibitors and cell cycle regulators with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P42773; product specifications from Assay Genie datasheets.